期刊
BRAIN RESEARCH
卷 1040, 期 1-2, 页码 29-35出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.brainres.2005.01.022
关键词
neuroactive steroid; neurosteroidogenesis; modulator of GABA(A) receptors; astrocyte; Alzheimer's disease; Down's syndrome
Allopregnanolone is a positive allosteric modulator of GABA(A) receptors, generated by the reduction of 5 alpha-dihydroprogesterone (5 alpha-DHP) in astrocytes. This neuroactive steroid can be inactivated by its 3 alpha-oxidation to yield 5 alpha-DHP. It was found that 5 alpha-DHP levels in HEK293 cells expressing type 10 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD10), but not its catalytic inactive mutant, increased significantly as allopregnanolone was added to culture media. The results demonstrate that mitochondrial 17 beta-HSD10 effectively catalyzes the intracellular oxidation of allopregnanolone. Moreover, brain astrocytes contain a moderate level of 17 beta-HSD10, which is elevated in activated astrocytes of brains with Alzheimer type pathology, including sporadic Alzheimer's disease (AD) and Down's syndrome with AD. The distribution of 17 beta-HSD10 was found not to parallel that of 3 alpha-HSD3. Cerebral cortex has the lowest level of 17 beta-HSD10; whereas the hippocampus, hypothalamus, and amygdala possess relatively higher levels of this enzyme. The catalysis of 17 beta-HSD10 appears to be essential for maintaining normal functions of GABAergic neurons. The elevated level of 17 beta-HSD10 in activated astrocytes is a new feature found in brains of people with AD, and it may have important impact on AD pathogenesis. (c) 2005 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据